IVW241220C97000
- 3.57
- 0.000.00%
Ishares S&P 500 Growth Etf Newsroom
Apple AirPods To Get Heart Rate, Temperature Sensors, And Cameras To Help With AI Features: Top Analyst
Trump Taps Sriram Krishnan As Senior AI Advisor — Elon Musk Agrees New David Sacks Underling 'Right Man For The Topic And The Time'
Express News | Nvidia Plans to Set up Taiwan Headquarters, Local Media Commercial Times Reports
'Sonic the Hedgehog 3' Races Past 'Mufasa: The Lion King' for First Place at Box Office
Quantum Computing, BlackBerry And Lucid Group Are Among Top Mid Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Quantum Computing: The New AI? A Look at the Rapidly Expanding Market and Top Stocks For 2025
Apple Developing Face ID Smart Doorbell To Unlock Doors By Late 2025
Insider Trades: Berkshire Adds OXY, Nvidia & Salesforce Among Notable Names This Week
Tech Titans Triumph: The Top 10 Billionaires Who Made Big Gains In 2024
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Apple's Home Strategy Has Struggled. Could That Change?
Ultraman angrily confronts Musk: he is just a "bully" who likes to "fight" with opponents.
Altman believes that Musk's hostility towards OpenAI largely stems from its success. He also mentioned that Musk had "high-profile" arguments with Jeff Bezos and Bill Gates.
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Short Sellers Targeting Major Auto Stocks, Growing Their Positions - S3 Partners
Deal Dispatch: Honeywell, Textron And Soho House Are Making M&A Moves
Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.
① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.
OpenAI Project to Improve ChatGPT Behind Schedule as Costs Soar: Report
As Quantum Computing Stocks Soar, Wall Street Analysts Take Bullish Stance
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market